strategy. The objective of this study was to assess the effectiveness (i.e., respondents' Results: The educational brochure was sent to a total of 565 HCPs; 121 (21.4%) responded to the survey. The majority of respondents (95.0%) had previously prescribed or dispensed the target medicine. In all, 88 (72.7%) respondents said they had received the educational brochure, of whom 95.5% stated they had at least scanned the main points. More participants who had received the brochure (86.4% to 96.6%) answered the five individual survey questions correctly compared with those who did not (51.5% to 97.0%); this was significant for four out of five questions (P B 0.005). Significantly more HCPs who received the brochure achieved the predefined 
METHODS

Study Design
This was a prospective, non-interventional, cross-sectional study. The TGA was consulted throughout the protocol development process. The HCP brochure distribution and subsequent survey were designed to be deployed to approximately 600 HCPs comprising medical To minimize bias in responses, the HCPs who were sent the survey had no face-to-face visits or contact with the sponsor's representatives to specifically discuss the HCP brochure or survey; in addition, survey questions were designed to be non-leading.
The survey was designed so that it could be completed from any electronic device.
Between September and October 2014, HCPs were sent an email with an invitation to participate in the online survey. The first invitation was sent 1 week after distribution of the HCP brochure, and reminders were sent to non-responders once a week over a 3-week period.
HCPs were offered a small monetary incentive to complete the survey. Unique IDs assigned to responders ensured that each respondent could participate only once in the survey.
Study Outcomes
The primary aims of the study were to: (CIOMS) IX report [5] . The study effectively assessed the first three levels of the Banerjee model using two main process indicators: awareness, which measured the coverage and awareness of the educational brochure across the target population of interest; and understanding/knowledge, which assessed target respondents' understanding of information contained in the brochure using five predefined multiple-choice questions.
For the purpose of the study, the educational brochure was considered to be a valid method for risk reduction if a predefined C80% of HCP respondents answered C80% (four out of five)
questions from Part 2 of the survey correctly.
Data Analysis
The data were summarized and analyzed descriptively based on the total number of HCPs who were sent the educational brochure to evaluate the defined process indicators. 
RESULTS
The final database included 574 HCPs who were sent the educational brochure. Seven HCPs in the database with undeliverable or disabled email addresses and two with out-of-office responses were removed from the study population, giving a final effective sample of 565 HCPs. Of these, 121 (21.4%) responded to the survey. The profile of the respondent sample is shown in Table 1 . Overall, the respondent sample reflected the structure of the original database, only with a slightly higher proportion of oncology pharmacists (Fig. 1) . 
Awareness
In all, 88 (72.7%) respondents said they had received the educational brochure (Fig. 2 ). More oncology pharmacists (87.5%) said they had received the brochure than did oncology clinicians (65.4%). Overall, 70.2% of the total survey participants (i.e., including those who had received and those who had not received) stated they had read the educational brochure.
Of those respondents who reported having received the educational brochure, a high proportion stated they had read it (95.5%), with similar findings in oncology pharmacists (97.1%) and oncology clinicians (94.3%). All other respondents who received the educational brochure stated that they intended to read it. Of those recipients who had read the educational brochure, the majority (65.9%) stated that they had scanned the main points, and more than a quarter (29.5%) stated that they had read it in detail (Fig. 2) . In the multiple-choice questions comprising Part 2 of the survey, each of the individual five survey questions, designed to assess the understanding of information in the brochure, was answered correctly by at least 76.0% of the total respondent sample; however, for the majority of questions, the proportion of respondents answering correctly was significantly higher in those who had received the educational brochure compared with those who did not (Fig. 3) .
DISCUSSION
The results of this study provide important insights into the effectiveness of an educational brochure as a post-marketing risk minimization The evaluation of the effectiveness of risk minimization interventions is a pivotal part of continuous pharmacovigilance, and an analysis of interventions implemented-and whether they have been successful in reducing risk-is crucial [7] . While proof of risk reduction is pivotal to any risk management strategy [7] , it is beyond the scope of this study. However, proof of implementation is an equally important step in risk management strategies and is necessary if we are to assess subsequent data regarding the reduction of risk. Should a particular strategy fail to reduce risk, assessment of implementation will help determine whether this failure arose at the implementation stage, or was the result of a conceptual error in the strategy itself [7] . Pharmaceutical companies primarily communicate risk through labeling tools such as the prescribing information, package insert, patient information leaflet, and the carton [2] .
However, the efficacy of such approaches has been poorly investigated, and recent research has raised concerns over the effectiveness of some of these methods [2] . The evidence behind the effectiveness of printed materials in disseminating information and influencing HCP behavior is inconclusive. A recent
Cochrane review looked at a range of studies evaluating the impact of the distribution of printed educational materials on HCP practice and patient outcomes [3] . This analysis included studies using a wide range of distribution techniques including personally addressed communications, communications delivered via mass mailings, and passively delivered communications utilizing broader communication channels (e.g., printable documents available on the Internet, mass media). The conclusion of the study was that printed educational materials, when used alone and compared with no intervention, have a small beneficial effect on professional practice outcomes [3] . The Cochrane analysis included only those studies assessing the impact of were more likely to correctly identify key issues in hepatitis C risk, prognosis, and management [9] . An Australian study investigating whether the distribution of electronic newsletters, containing case studies and lessons learned on deaths in residential care, could influence HCPs found that around half of the respondents to the survey reported changing their professional practice as a result of reading the communiqués, with around one-fifth agreeing they would not have made the changes if they had not read the publication [10] .
Our study has a number of strengths. The survey performed in this study was in line with United States Food and Drug Administration (FDA)-recommended practice for survey methodologies used to assess the effectiveness of risk evaluation and mitigation strategies [6] . Key risk messages were identified, and the questionnaire developed to target these key risk messages. By using the STA database, we were able to target relevant HCPs (i.e., those who used, prescribed, and/or dispensed the target medicine) and provide a representative sample of the entire population of product users. This along with avoidance of the use of leading questions limited bias. The short length of the survey, which was easy to complete using any electronic device, minimized the burden imposed on the survey participants. Shorter and simpler documents have the potential to facilitate more effective and efficient uptake of key information, given that HCPs may not have time to screen and appraise new scientific literature [3] , or to read longer formal documents such as full prescribing information in detail.
In addition, by asking the question ''Did you read the brochure: Yes or No?'' we were able to provide a comparator group which is often lacking in studies of this type. This was a prospective study with a predefined measure of success (pass rate). Finally, we consulted with and received input from the regulator in the design of the study and outcomes.
There are limitations inherent to the nature of this study which should be considered. In common with many other survey-based studies, responder bias (only around one-fifth of HCPs responded to the survey) may have influenced the results of the current study, and the results may not be generalizable to a wider population or to other clinical areas. HCPs, particularly clinicians, generally show a low rate of response to surveys-and the rate of response has declined over recent decades [11] [12] [13] .
However, and despite these limitations, surveys are an efficient, inexpensive, and flexible means of collecting information from a large pool of respondents and an important means of assessing and evaluating information dissemination [12, 13] . For the current study, the results of the survey were accepted by the TGA to demonstrate the effectiveness of the educational brochure as an enhanced risk minimization activity for nab-paclitaxel, and it was agreed that repeat distribution of the educational brochure was not necessary. 
CONCLUSIONS
